High multi-cytokine levels are not a predictive marker of alloimmunization in transfused sickle cell disease patients

Zohreh Tatari Calderone, Ross M. Fasano, Megan R. Miles, Ligia A. Pinto, Naomi L C Luban, Stanislav Vukmanovic

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Patients with sickle cell disease (SCD) receive multiple red blood cell (RBC) transfusions for both prevention of and therapy for disease-related complications. In some patients, transfusion results in development of both allo- and auto-antibodies to RBC antigens. What precipitates the antibody formation is currently unclear. It has been hypothesized that a pro-inflammatory state preceding the therapeutic transfusion may be a predisposing factor. Plasma levels of ten cytokines were evaluated upon recruitment to the study of 83 children with SCD undergoing therapeutic RBC transfusions. The levels of cytokines were correlated with development of anti-RBC antibodies prior, or during seven years post recruitment. Twelve subjects displayed significantly higher levels of all cytokines examined, with pro-, as well as anti-inflammatory properties. Surprisingly, the elevated levels of cytokines were preferentially found in patients without anti-RBC allo- and/or auto-antibodies. Further, presence of high cytokine levels was not predictive of anti-RBC antibody development during the subsequent seven year follow up. These data suggest that the increased concentration of multiple cytokines is not a biomarker of either the presence of or susceptibility to the development of RBC alloimmunization.

Original languageEnglish
Pages (from-to)59-64
Number of pages6
JournalCytokine
Volume68
Issue number1
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Sickle Cell Anemia
Blood
Cytokines
Erythrocytes
Antibodies
Erythrocyte Transfusion
Causality
Biomarkers
Antibody Formation
Anti-Inflammatory Agents
Therapeutics
Precipitates
Antigens
Cells
Plasmas

Keywords

  • Antibodies
  • Cytokines
  • Inflammation
  • Red blood cell transfusion
  • Sickle cell disease

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Hematology
  • Biochemistry
  • Molecular Biology
  • Medicine(all)

Cite this

High multi-cytokine levels are not a predictive marker of alloimmunization in transfused sickle cell disease patients. / Tatari Calderone, Zohreh; Fasano, Ross M.; Miles, Megan R.; Pinto, Ligia A.; Luban, Naomi L C; Vukmanovic, Stanislav.

In: Cytokine, Vol. 68, No. 1, 2014, p. 59-64.

Research output: Contribution to journalArticle

Tatari Calderone, Zohreh ; Fasano, Ross M. ; Miles, Megan R. ; Pinto, Ligia A. ; Luban, Naomi L C ; Vukmanovic, Stanislav. / High multi-cytokine levels are not a predictive marker of alloimmunization in transfused sickle cell disease patients. In: Cytokine. 2014 ; Vol. 68, No. 1. pp. 59-64.
@article{fbae5155dac143ecb6183edbe77df4b8,
title = "High multi-cytokine levels are not a predictive marker of alloimmunization in transfused sickle cell disease patients",
abstract = "Patients with sickle cell disease (SCD) receive multiple red blood cell (RBC) transfusions for both prevention of and therapy for disease-related complications. In some patients, transfusion results in development of both allo- and auto-antibodies to RBC antigens. What precipitates the antibody formation is currently unclear. It has been hypothesized that a pro-inflammatory state preceding the therapeutic transfusion may be a predisposing factor. Plasma levels of ten cytokines were evaluated upon recruitment to the study of 83 children with SCD undergoing therapeutic RBC transfusions. The levels of cytokines were correlated with development of anti-RBC antibodies prior, or during seven years post recruitment. Twelve subjects displayed significantly higher levels of all cytokines examined, with pro-, as well as anti-inflammatory properties. Surprisingly, the elevated levels of cytokines were preferentially found in patients without anti-RBC allo- and/or auto-antibodies. Further, presence of high cytokine levels was not predictive of anti-RBC antibody development during the subsequent seven year follow up. These data suggest that the increased concentration of multiple cytokines is not a biomarker of either the presence of or susceptibility to the development of RBC alloimmunization.",
keywords = "Antibodies, Cytokines, Inflammation, Red blood cell transfusion, Sickle cell disease",
author = "{Tatari Calderone}, Zohreh and Fasano, {Ross M.} and Miles, {Megan R.} and Pinto, {Ligia A.} and Luban, {Naomi L C} and Stanislav Vukmanovic",
year = "2014",
doi = "10.1016/j.cyto.2014.03.008",
language = "English",
volume = "68",
pages = "59--64",
journal = "Cytokine",
issn = "1043-4666",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - High multi-cytokine levels are not a predictive marker of alloimmunization in transfused sickle cell disease patients

AU - Tatari Calderone, Zohreh

AU - Fasano, Ross M.

AU - Miles, Megan R.

AU - Pinto, Ligia A.

AU - Luban, Naomi L C

AU - Vukmanovic, Stanislav

PY - 2014

Y1 - 2014

N2 - Patients with sickle cell disease (SCD) receive multiple red blood cell (RBC) transfusions for both prevention of and therapy for disease-related complications. In some patients, transfusion results in development of both allo- and auto-antibodies to RBC antigens. What precipitates the antibody formation is currently unclear. It has been hypothesized that a pro-inflammatory state preceding the therapeutic transfusion may be a predisposing factor. Plasma levels of ten cytokines were evaluated upon recruitment to the study of 83 children with SCD undergoing therapeutic RBC transfusions. The levels of cytokines were correlated with development of anti-RBC antibodies prior, or during seven years post recruitment. Twelve subjects displayed significantly higher levels of all cytokines examined, with pro-, as well as anti-inflammatory properties. Surprisingly, the elevated levels of cytokines were preferentially found in patients without anti-RBC allo- and/or auto-antibodies. Further, presence of high cytokine levels was not predictive of anti-RBC antibody development during the subsequent seven year follow up. These data suggest that the increased concentration of multiple cytokines is not a biomarker of either the presence of or susceptibility to the development of RBC alloimmunization.

AB - Patients with sickle cell disease (SCD) receive multiple red blood cell (RBC) transfusions for both prevention of and therapy for disease-related complications. In some patients, transfusion results in development of both allo- and auto-antibodies to RBC antigens. What precipitates the antibody formation is currently unclear. It has been hypothesized that a pro-inflammatory state preceding the therapeutic transfusion may be a predisposing factor. Plasma levels of ten cytokines were evaluated upon recruitment to the study of 83 children with SCD undergoing therapeutic RBC transfusions. The levels of cytokines were correlated with development of anti-RBC antibodies prior, or during seven years post recruitment. Twelve subjects displayed significantly higher levels of all cytokines examined, with pro-, as well as anti-inflammatory properties. Surprisingly, the elevated levels of cytokines were preferentially found in patients without anti-RBC allo- and/or auto-antibodies. Further, presence of high cytokine levels was not predictive of anti-RBC antibody development during the subsequent seven year follow up. These data suggest that the increased concentration of multiple cytokines is not a biomarker of either the presence of or susceptibility to the development of RBC alloimmunization.

KW - Antibodies

KW - Cytokines

KW - Inflammation

KW - Red blood cell transfusion

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=84899957050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899957050&partnerID=8YFLogxK

U2 - 10.1016/j.cyto.2014.03.008

DO - 10.1016/j.cyto.2014.03.008

M3 - Article

C2 - 24746244

AN - SCOPUS:84899957050

VL - 68

SP - 59

EP - 64

JO - Cytokine

JF - Cytokine

SN - 1043-4666

IS - 1

ER -